FEB 25, 2020 9:00 AM PST

CAR-T Generation for Identity, Purity and Potency Assay Testing

Speaker

Abstract
DATE:  February 25, 2020
TIME:  9:00am PST, 12:00pm EST
 
Chimeric antigen receptor T-Cell (CAR-T) therapy has been approved by FDA to treat B-cell leukemias and has seen great clinical success. CAR-T cell manufacturing involves isolating T-cells from a patient, cell activation, engineering in the CAR construct, and expanding the cells to a therapeutic dose. To ensure patient safety and product quality, a number of quality control (QC) tests must be performed throughout the manufacturing process and for product release. These include confirming the identity, purity, and potency of the final CAR-T product. Often times, these assays are procured by multiple sources and may vary in performance resulting in inconsistent outcomes and product quality. To address these issues, CAR-T cells were generated in-house and used for the development and optimization of CAR-T specific characterization tools. T-cells were isolated from healthy donors, expanded in vitro, and transduced with a second generation (CD3ζ and 4-1BB) anti-CD19 CAR lentivirus. Using a clinically relevant workflow, expression of the CAR construct was obtained in a high, consistent manner. These CAR-T cells were then extensively characterized with pertinent analytical assays. In particular, PureQuant Methylation assay was used to measure percent of CD4/CD8 cells and also detect contaminating B cells and monocytes to high level of sensitivity. Our presented work flow details optimized methods of CAR-T Cell characterization that may be used in pre-clinical and clinical CAR-T manufacturing, following proper validation and regulatory approval.
 
Learning Objectives:
  • Show a small-scale CAR-T workflow using ThermoFisher products
  • Highlight characterization tools that can be utilized and applied in a CAR-T workflow
 
Watch our related webinars here:
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
FEB 25, 2020 9:00 AM PST

CAR-T Generation for Identity, Purity and Potency Assay Testing



Show Resources
Loading Comments...
Show Resources